Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.

Chakos MH, Glick ID, Miller AL, Hamner MB, Miller DD, Patel JK, Tapp A, Keefe RS, Rosenheck RA.

Psychiatr Serv. 2006 Aug;57(8):1094-101.

PMID:
16870959
2.

Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.

Chakos M, Patel JK, Rosenheck R, Glick ID, Hammer MB, Tapp A, Miller A, Miller D.

Clin Schizophr Relat Psychoses. 2011 Oct;5(3):124-34. doi: 10.3371/CSRP.5.3.2. Erratum in: Clin Schizophr Relat Psychoses. 2012 Jan;5(4):184. Miller, Del [added].

PMID:
21983496
3.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
4.
5.

Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior.

Glick ID, Zaninelli R, Hsu C, Young FK, Weiss L, Gunay I, Kumar V.

J Clin Psychiatry. 2004 May;65(5):679-85.

PMID:
15163255
6.

Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.

Mallinger JB, Lamberti SJ.

J Ment Health Policy Econ. 2007 Mar;10(1):15-22.

PMID:
17417044
7.

Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury.

Hammond FM, Barrett RS, Shea T, Seel RT, McAlister TW, Kaelin D, Ryser DK, Corrigan JD, Cullen N, Horn SD.

Arch Phys Med Rehabil. 2015 Aug;96(8 Suppl):S256-3.e14. doi: 10.1016/j.apmr.2015.01.025.

8.
9.

How psychotropic polypharmacy in schizophrenia begins: a longitudinal perspective.

Shinfuku M, Uchida H, Tsutsumi C, Suzuki T, Watanabe K, Kimura Y, Tsutsumi Y, Ishii K, Imasaka Y, Mimura M, Kapur S.

Pharmacopsychiatry. 2012 Jun;45(4):133-7. doi: 10.1055/s-0031-1297934. Epub 2011 Dec 15.

PMID:
22174025
10.

The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric hospital.

Parepally H, Chakravorty S, Levine J, Brar JS, Patel AM, Baird JW, Chalasani L, Delaney JA, Atzert R, Chengappa KN.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Apr;26(3):437-40.

PMID:
11999892
11.

Non-adherence with psychotropic medications in the general population.

Bulloch AG, Patten SB.

Soc Psychiatry Psychiatr Epidemiol. 2010 Jan;45(1):47-56. doi: 10.1007/s00127-009-0041-5. Epub 2009 Apr 4.

PMID:
19347238
12.

Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.

Baldessarini R, Henk H, Sklar A, Chang J, Leahy L.

Psychiatr Serv. 2008 Oct;59(10):1175-83. doi: 10.1176/appi.ps.59.10.1175.

PMID:
18832504
13.

Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.

Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC.

Psychiatr Serv. 2007 Apr;58(4):489-95.

14.

Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey.

Magliano L, Fiorillo A, Guarneri M, Marasco C, De Rosa C, Malangone C, Maj M; National Mental Health Project Working Group..

Eur J Clin Pharmacol. 2004 Sep;60(7):513-22.

PMID:
15316703
15.

Common use of anticholinergic medications in older patients with schizophrenia: findings of the Research on Asian Psychotropic Prescription Pattern (REAP) study, 2001-2009.

Xiang YT, Dickerson F, Kreyenbuhl J, Ungvari GS, Wang CY, Si TM, Lee EH, Chiu HF, Lai KY, He YL, Yang SY, Chong MY, Tan CH, Kua EH, Fujii S, Sim K, Yong MK, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Shinfuku N.

Int J Geriatr Psychiatry. 2013 Mar;28(3):305-11. doi: 10.1002/gps.3827. Epub 2012 May 7.

PMID:
22565547
16.

Use of psychotropic medications among HIV-infected patients in the United States.

Vitiello B, Burnam MA, Bing EG, Beckman R, Shapiro MF.

Am J Psychiatry. 2003 Mar;160(3):547-54.

PMID:
12611837
17.

Trends in treatment of newly treated schizophrenia-spectrum disorder patients in Taiwan from 1999 to 2006.

Wu CS, Lin YJ, Feng J.

Pharmacoepidemiol Drug Saf. 2012 Sep;21(9):989-96. doi: 10.1002/pds.3254. Epub 2012 Mar 14.

PMID:
22416032
18.

Polypharmacy in patients with schizophrenia.

McCue RE, Waheed R, Urcuyo L.

J Clin Psychiatry. 2003 Sep;64(9):984-9.

PMID:
14628972
19.

Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis.

Waterreus A, Morgan VA, Castle D, Galletly C, Jablensky A, Di Prinzio P, Shah S.

Aust N Z J Psychiatry. 2012 Aug;46(8):762-73. doi: 10.1177/0004867412450471. Epub 2012 Jun 11.

PMID:
22689337
20.

Concomitant medication of psychoses in a lifetime perspective.

Vares M, Saetre P, Strålin P, Levander S, Lindström E, Jönsson EG.

Hum Psychopharmacol. 2011 Jun-Jul;26(4-5):322-31. doi: 10.1002/hup.1209. Epub 2011 Jun 22.

Supplemental Content

Support Center